Contact
 
News about the Enterprise

Call for Applications: YECI Workshop on Statistical Methods - February 15, 2012

The OCTAVE Project, the South African MRC, HVTN and SCHARP are soliciting applications for a workshop  for YECIs on key statistical considerations for the design and analysis of HIV vaccine trials. Click the PDF below for more details.

 RFA: New OCTAVE Workshop for Young and Early Career

AIDS Vaccine 2012 Registration Now Open - February 10, 2012

Join us for AIDS Vaccine 2012 in Boston, 9 - 12 September 2012.  For additional details, visit www.vaccineenterprise.org/conference/2012.

Enterprise Seeks Director of Secretariat - January 18, 2012

The Enterprise Board has begun recruiting qualified candidates to serve as Director of the Enterprise Secretariat; the job posting can be found on the Enterprise web site at http://www.vaccineenterprise.org/content/careers.  

AIDS Vaccine 2011 Wrap Up Report - January 6, 2012

The AIDS Vaccine 2011 conference was attended by more than 820 researchers, representing 45 countries, and among the highlights was the exciting discussion around the results of the two-year case-controlled studies of RV144.  

Correlates of Protection and HIV Vaccine Development - October 28, 2011

The Lancet published a piece on correlates of protection and HIV vaccine development in its November issue.  Click below to read the article.

AIDS Vaccine 2011 to Open in Bangkok - September 7, 2011

In the midst of the most promising era in HIV prevention research since the AIDS epidemic began, scientists from around the world will present more than 400 new studies outlining advances in the search for a safe and effective HIV vaccine at AIDS Vaccine 2011.  This global conference, the world’s only scientific meeting dedicated exclusively to HIV vaccine research, runs Monday, 12 September through Thursday, 15 September in Bangkok.  This is the first time that the annual AIDS Vaccine conference has been held in Asia.

Request for Applications: Workshop on Statistical Methods in HIV Vaccine Trial Design and Evaluation - June 10, 2011

New Enterprise-OCTAVE Workshop for Young and Early Career Investigators

Statistical Methods in HIV Vaccine Trial Design and Evaluation

11-12 September 2011 Bangkok, Thailand (prior to AIDS Vaccine 2011)

Dr. Alan Bernstein Stepping Down As Executive Director of the Global HIV Vaccine Enterprise - June 8, 2011

The Board of Directors of the Global HIV Vaccine Enterprise today announced that Alan Bernstein, Ph.D. will step down after three and a half years as the inaugural executive director of the Enterprise Secretariat at the end of June 2011.   The full announcement is below.

Request for Applications: Workshop on Adjuvants and HIV Vaccine Development - April 6, 2011

The Global HIV Vaccine Enterprise and the OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation), are accepting applications for a new workshop focused on adjuvants and their critical role in enhancing vaccine immunogenicity.  This two-day workshop, which blends eLearning and face-to-face training, is the fourth in a series of six capacity-building workshops aimed at providing young and early-career investigators (YECIs) with the tools to further their careers in HIV vaccine research and development.  The call for applications is below.

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account